RELATED: Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey Bar-Zohar emphasized that the study was not connected to the commercialization of Aimovig but rather had the goal of studying and understanding the economic, social and emotional impact of migraines. Novartis and Amgen launched a migraine awareness campaign last year called "Speak Your Migraine" in digital and social. The two companies will leverage data from the Migraine Voice study into that awareness campaign, but those plans are still developing, a Novartis spokesperson said.